Call to enlist pharmacists for opioid fight as deaths rise
New Australian Institute of Health and Welfare (AIHW) research has revealed the number of Australian deaths involving opioids has more than doubled in the...
Five funding recommendations to improve medicine safety
Increased funding for pharmacists in aged care and rural and remote communities would save lives and improve health outcomes, PSA has argued in its...
Medicinal cannabis goes mainstream, but safety concerns are growing
Once considered a fringe therapy, medicinal cannabis is rapidly becoming a mainstream prescribing option. As demand surges, pharmacists are left managing clinical risks and patient expectations while regulators struggle to keep up. But is this starting to change?
Opioids, antidepressants and the risk of hip fracture
A recent study identified that the risk of hip fracture was increased with the use of psychotropic drugs in elderly people. The highest risk...
From the President: Inequitable consumer access to care a priority for...
As the 21 May election draws close, PSA’s election platform has renewed calls to prioritise better consumer access to healthcare through fairer remuneration for pharmacist-delivered services.
A founding hand in the Home Medicines Review
PSA 2026 Lifetime Achievement recipient Carlene Smith AM has shaped medicines management nationwide through her leadership in HMRs.
